bioRxivMicrobiologyPreprint
Inhibition of Neisseria gonorrhoeae complement-mediated killing during acute gonorrhoea is dependent upon the IgG2:IgG3 antibody ratio
S. A. McKeand, S. E. Faustini, A. Cook, N. Kennett, M. T. Drayson, A. F. Cunningham, I. R. Henderson, J. D. C. Ross, J. A. Cole, A. E. Rossiter-Pearson
Abstract
Excessive binding of antibodies to the bacterial cell surface can paradoxically increase resistance of some Gram-negative pathogens to complement-mediated killing (CMK). We examined CMK of 336 Neisseria gonorrhoeae clinical isolates sampled from participants recruited to a clinical trial. Serum bactericidal assays revealed 3% (9/336) of the autologous participant sera that were tested inhibited CMK. Gonococci isolated from these participants were resistant to the autologous host serum, sensitive to a pool of healthy control sera (HCS) and protected by the host serum in a 1:1 mixture with HCS. Analysis of the clinical metadata showed that there were a significantly higher proportion of inhibitory sera found in participants with urethral infections and from men within the transmission network of men who have sex with women (MSW), when compared to the whole cohort. Following antibody purification from selected participants with inhibitory sera (5/9), IgG and IgM protected the autologous isolates from HCS-mediated killing. Only three of these isolates were protected by purified IgA. A closer examination of IgG subclasses using whole gonococcal cell ELISAs revealed a strong correlation between increased IgG2 binding and decreased IgG3 binding to the bacterial cell surface of isolates that were resistant to CMK. This suggests that IgG2 prevents bactericidal IgG3 from initiating CMK and that the IgG2:IgG3 ratio is important for determining either inhibition or killing of isolates. We therefore reveal a previously unreported mechanism by which inhibitory antibodies prevent CMK of N. gonorrhoeae.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Terminal complement complexes with or without C9 potentiate antimicrobial activity against Neisseria gonorrhoeae
Evan R. Lamb, Alison K. Criss·mBioPeer-reviewed·Apr 14, 2025
- Neisseria gonorrhoeae co-opts C4b-binding protein to enhance complement-independent survival from neutrophils
L. M. Werner, A. Alcott, … A. K. Criss·bioRxiv·Dec 8, 2022
- Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae
Jutamas Shaughnessy, Jintang Du, … Sanjay Ram·PLoS ONEPeer-reviewed·Aug 25, 2026
- Commensal Neisseria species share immune suppressive mechanisms with Neisseria gonorrhoeae
W. Zhu, M. X. Cardenas-Alvarez, … R. Nicholas·bioRxiv·Aug 19, 2022
- C4BP occludes the non-opsonic interaction of Neisseria gonorrhoeae with human neutrophil CEACAMs
Mary E. Wakim, Jutamas Shaughnessy, … Alison K. Criss·Infection and ImmunityPeer-reviewed·Jun 10, 2026
- Neisseria gonorrhoeae scavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation
A. Cardenas, K. S. Thomas, … A. K. Criss·bioRxiv·Jan 17, 2024